Clinical trial
Evaluation of Plasma Non-coding RNAs (miRNA-320a) as Biomarkers of Diagnosis, Prognosis and Treatment Effects in Coronary Heart Disease
NCT02751060 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Plasma Non-coding RNAs (miRNA-320a) as Biomarkers of Diagnosis, Prognosis and Treatment Effects in Coronary Heart Disease
- Lead sponsor
- Tongji Hospital
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- April 30, 2016
- Completion date
- December 31, 2026
- Enrollment
- 4,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.